Viewing Study NCT00044759


Ignite Creation Date: 2025-12-24 @ 2:35 PM
Ignite Modification Date: 2026-02-22 @ 5:08 PM
Study NCT ID: NCT00044759
Status: COMPLETED
Last Update Posted: 2007-10-10
First Post: 2002-09-04
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Study Comparing the Safety and Efficacy of Piperacillin/Tazobactam to Cefepime in Patients With Hematologic Malignancy or Lymphoma
Sponsor: Wyeth is now a wholly owned subsidiary of Pfizer
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Eligibility Module Contacts Locations Module